QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 21, 页码: 9053-9066 作者:  Shao, Li-Dong;  Su, Jia;  Ye, Baixin;  Liu, Jiang-Xin;  Zuo, Zhi-Li 收藏  |  浏览/下载：58/0  |  提交时间：2017/12/18 Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation 期刊论文 MARINE DRUGS, 2017, 卷号: 15, 期号: 11, 页码: 18 作者:  Wang, Li-Jun;  Guo, Chuan-Long;  Li, Xiang-Qian;  Wang, Shuai-Yu;  Jiang, Bo 收藏  |  浏览/下载：55/0  |  提交时间：2019/07/15 bromophenol hybrids  anticancer  structure-activity relationships  ROS  apoptotic pathway   Synthesis and biological evaluation of benzothiazol-based 1,3,4-oxadiazole derivatives as amyloid beta-targeted compounds against Alzheimer's disease 期刊论文 MONATSHEFTE FUR CHEMIE, 2017, 卷号: 148, 期号: 10, 页码: 1807-1815 作者:  Mei, Wen-wen;  Ji, Sha-sha;  Xiao, Wei;  Wang, Xue-dong;  Jiang, Cheng-shi 收藏  |  浏览/下载：62/0  |  提交时间：2019/01/08 Structure-activity relationships  Heterocycles  Drug research  Neuroprotective effects   Synthesis and glucose-stimulate insulin secretion (GSIS) evaluation of vindoline derivatives 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 卷号: 27, 期号: 5, 页码: 1316-1318 作者:  Xiao, Chengqian;  Tian, Yunan;  Lei, Min;  Chen, Fanglei;  Gan, Xianwen 收藏  |  浏览/下载：23/0  |  提交时间：2019/01/08 Vindoline  Natural product  Glucose-stimulate insulin secretion (GSIS)  Structure-activity relationships (SARs)   Development of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies 期刊论文 ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 卷号: 17, 期号: 5, 页码: 646-657 作者:  Guan, Haixing;  Du, Yongli;  Han, Weiwei;  Shen, Jingkang;  Li, Qunyi 收藏  |  浏览/下载：19/0  |  提交时间：2019/01/08 Anti-cancer agents  cell cycle  clinical trials  cyclin-dependent kinases 4  selective inhibitors  structure activity relationship (SAR)